Inside information is information that could have a significant impact on the stock price of financial instruments.
Regulated information
Inside information is regulated information.
Specific disclosure and storage obligations apply to regulated information:
- Dissemination (or disclosure) – to be done using media and in a manner ensuring fast access to such information on a non-discriminatory basis to as wide a public as possible.
- Storage - regulated information is to be made available on:
- the issuer’s website.
- eCorporate. Regulated information uploaded to eCorporate is automatically recorded in STORI.
To learn more about technical requirements regarding the publication of regulated information, please refer to
Deadlines
Inside information must be disclosed as soon as possible. If the disclosure is made during stock exchange hours, trading in the stock will, in principle, have to be suspended.
To learn more about obligations with respect to inside information, please refer to Circular FSMA_2012_01, section 4 (available in French and Dutch only).
The FSMA has published an Opinion on the disclosure of inside information by listed biotech companies. It is intended, by the provision of considerations and good practices, to assist those companies in complying with the inside information disclosure requirements and thus in preventing market abuse infringements.
Suspension of trading during an ABB: when securities are privately placed through an “accelerated book building” process (ABB), the FSMA follows a policy of suspending trading in the share during the ABB. To arrange the suspension prior to the operation, as well as for questions concerning the communication of inside information, please contact:
- telephone: 02 220 59 00
- e-mail: info.fin@fsma.be